TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/6/23 19:41 | 12/5/23 | ERAS | Erasca, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lim Jonathan E | CA | DOT | CB,CEO | P.m | 1,696 | 1.70 | 0 | 1,000 | 3 | 32,356 | I | ||||||||||||||
10/10/23 08:00 | 10/5/23 | ERAS | Erasca, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lim Jonathan E | CA | DOT | CB,CEO | P | 2,026 | 2.03 | 0 | 1,000 | 3 | 31,356 | I | ||||||||||||||
6/8/23 20:54 | 6/8/23 | ERAS | Erasca, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lim Jonathan E | CA | DOT | CB,CEO | P | 275 | 2.75 | 0 | 100 | 0 | 30,296 | I | ||||||||||||||
3/28/23 21:24 | 3/28/23 | ERAS | Erasca, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lim Jonathan E | CA | DOT | CB,CEO | P | 284 | 2.84 | 0 | 100 | 0 | 30,196 | I | ||||||||||||||
1/10/23 16:46 | 1/10/23 | ERAS | Erasca, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lim Jonathan E | CA | DOT | CB,CEO | P | 231 | 3.86 | 0 | 60 | 0 | 32,156 | I | ||||||||||||||
12/15/22 11:53 | 12/14/22 | ERAS | Erasca, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lim Jonathan E | CA | DOT | CB,CEO | P | 200 | 4.99 | 0 | 40 | 0 | 32,096 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |